Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Corem signs lease agreement with Transcom for 1,067 sq.m. in Kista

Corem has signed a three-year lease agreement with the global outsourcing company Transcom regarding a 1,067 square meter office space in the property Borgarfjord 4 in Kista, Stockholm. Access is planned for the first quarter of 2025.  Transcom already has its customer service operations in Kista and is now looking forward to new, fresh premises: "Kista offers many advantages. With excellent communications and proximity to Arlanda, it is a strategically smart location. There is also a strong recruitment base here, and we are close to several of our partners, whose

ABGSC – Q3 2024 Interim Report

Highlights:  ·Q3 revenues of NOK 392m (+10%)  ·Q3 diluted EPS of NOK 0.09 (+29%)  ·YTD revenues of NOK 1,305m (+12%)  ·YTD diluted EPS of NOK 0.35 (+35%)  CEO comment:   Following the quarter marking the 40th anniversary of our firm, I am very pleased to report one of the strongest third quarters ever. In what is a seasonally slow quarter, we saw robust activity in investment banking transactions and revenues coming close to the NOK 400m mark. This implies 10% growth in the quarter and 12% YTD, lifting our YTD EPS by 35%. This once again demonstrates the

Kährs BondCo explores the possibility to issue senior secured floating rate bonds and announces a tender offer, its intention to early redeem its outstanding bonds and provides a financial update

Kährs BondCo AB (publ) (the "Company") hereby announces that it has mandated DNB Markets, a part of DNB Bank ASA, Sweden Branch, Nordea Bank Abp and Pareto Securities AS as joint bookrunners to explore the possibility to place an up to SEK 1,450,000,000 senior secured floating rate bonds issue with a framework of up to SEK 2,500,000,000, subject to market conditions (the "New Bonds").The proceeds from the potential bond issue will be used to repurchase and/or redeem all of the Company's Existing Bonds (as defined below), finance general corporate purposes of the group and transaction costs

Cereno Scientific pivots to rare disease Idiopathic Pulmonary Fibrosis (IPF) as the initial target indication for novel HDAC inhibitor CS014 – strengthens Company focus on rare diseases

Cereno Scientific (Nasdaq First North: CRNO B), a pioneering biotech developing innovative treatments for diseases with high unmet medical needs, today announced that the Company has selected rare disease Idiopathic Pulmonary Fibrosis (IPF) as the initial target indication for novel HDACi CS014. This decision follows recent preclinical results showing significant reductions in pulmonary artery occlusion and fibrosis. With this move, Cereno strengthens its focus on rare diseases, reinforcing its commitment to addressing the significant needs of patients affected by these conditions.“At

Spinnova teams up with premium bag brand, ASK Scandinavia

SPINNOVA PLC, PRESS RELEASE, 17 October 2024, 09.00 a.m. EEST    Spinnova teams up with premium bag brand, ASK Scandinavia   Spinnova and ASK Scandinavia collaborate to bring a naturally dyed handbag to the market in 2025. The visually striking yet practical work tote bag is made with fabric that contains 30% wood-based SPINNOVA® fibres and 70% cotton. The fabric has been dyed with Natural Indigo Finland’s natural dye, made from Paulig’s coffee waste. This is the first commercially available product containing SPINNOVA® fibres coloured with natural dyes. The bag will be

Fondia Plc: Business Review for July–September 2024 will be published on October 24, 2024 – welcome to an investor call

Fondia Plc   Press release  17.10.2024 at 8.30 a.m. EEST    Fondia Plc will publish the Business Review for July–September 2024 on Thursday, October 24, 2024, at approximately 8.30 a.m. EEST. The company release on the Business Review will available after publishing on the company’s website https://investors.fondia.com/fi/en/releases-and-publications/reports-and-presentations.   An investor call will be held on Thursday, October 24, 2024, at 10.00 a.m. EEST. The investor call will be held in Finnish and can be accessed online by registering on the company’s website https://

Kindred Group announces third quarter revenue as part of tender offer by La Française des Jeux

Kindred Group announces third quarter total revenue in connection with La Française des Jeux’s (FDJ) tender offer to acquire Kindred Group. In its 9 months revenue press release to be published after the market closes on 17 October, FDJ will disclose combined group revenue with Kindred revenue estimated on the basis of the scope that would effectively be retained by FDJ. Kindred’s revenue and share of locally regulated Gross winnings revenue for the third quarter 2024 are in line with expectations and Kindred remains on track towards its full-year EBITDA guidance.Kindred Group plc (Kindred)

Hansa Biopharma Reports Third Quarter and Interim January - September 2024 Financial Results

Q3 2024 marks highest ever in-market quarterly sales performance and fourth consecutive quarter of strong sales performanceLund, Sweden, October 17, 2024, Hansa Biopharma today announced its interim report for January-September and third quarter 2024 financial results. Søren Tulstrup, President and CEO, Hansa Biopharma said, “The third quarter of 2024 marks the highest ever IDEFIRIX[®] sales performance to date, resulting in four consecutive quarters of strong sales performance. The launch of IDEFIRIX in Europe continues to advance with adoption in international organ allocation systems

Invitation to presentation of Bactiguard’s interim report for the third quarter 2024

Bactiguard Holding AB (publ) publishes its interim report for the third quarter on Thursday 24 October 2024 at 07:00 CET.In connection with this, Bactiguard will host an audiocast for investors, analysts, and media at 11:00 CET. CEO Christine Lind will present the report and answer questions together with CFO Patrick Bach. The report and a presentation will be available at ir.bactiguard.com . To participate in the audiocast, please use this link: ir.bactiguard.com/report/q3-2024/To participate only by conference call, please register via the

Arjo’s interim report January-September 2024

”Growth continued in the quarter with a strengthened order book and improved gross margin. Our performance was, however, held back by weaker demand in Europe. We are now accelerating initiatives to improve both short- and long-term profitability. We enter the final quarter of the year with high activity level and expect to reach our ambition of 3-5% organic growth for the full-year,” says Joacim Lindoff, President and CEO of Arjo. July-September 2024 in brief · Net sales amounted to SEK 2,734 M (2,777). Net sales grew organically by 1.5%. · The gross margin increased to 42.0%

Skanska upgrades substation in Oslo, Norway, for NOK 385M, about SEK 380M

Skanska has signed a contract with Statnett SF to upgrade and expand the Ulven substation in Oslo, Norway. The contract is worth NOK 385M, about SEK 380M, which will be included in the Nordic order bookings for the fourth quarter of 2024.The Ulven substation project is part of an upgrading of the central grid in Oslo. It is a design-build contract that includes demolition of existing buildings, foundation work and construction of new transformer shafts and new buildings, including technical solutions. The construction work will start in October 2024, and the project is expected to be

EQT AB (publ) Q3 Announcement 2024

Focus on value creation and realizations “Throughout the third quarter, we continued to execute on a strong pipeline of thematic investment opportunities, drive value creation across the portfolio and systematically pursue realizations. We are taking advantage of improving capital markets to increase exit activity, but risks remain elevated due to an uncertain geopolitical outlook.” Christian Sinding,CEO and Managing PartnerHighlights for the period Jul-Sep 2024 (Jul-Sep 2023) Strategic · EQT launched fundraising for EQT Private Capital Asia’s BPEA IX and set the target fund

Third-quarter results 2024

Nordea Bank AbpInterim report (Q1 and Q3)17 October 2024 at 7.30 EET Summary of the quarter Continued income growth. Total income was up 2%. Net interest income was 1% lower, following policy rate reductions. Net fee and commission income continued to grow, up 4%. Net insurance result remained solid and net fair value result improved by 26%. Costs rose by 9%, excluding a EUR 32m item related to the settlement of a regulatory investigation in the US. More than half of this increase was attributable to higher investment in growth, technology and risk management. Operating profit

ECB approves Nordea’s share buy-back application; Nordea to launch share buy-back programme of up to EUR 250 million

Nordea Bank AbpStock exchange release – Other information disclosed according to the rules of the Exchange17 October 2024 at 7.15 EET Nordea has received approval from the European Central Bank (ECB) for further share buy-backs of EUR 250 million, and Nordea’s Board of Directors has today in accordance with the authorisation granted by the 2024 Annual General Meeting decided on a share buy-back programme of up to EUR 250 million. The programme will commence on 21 October 2024 or as soon as possible after that date. The purpose of the buy-backs is to maintain an efficient capital

Changes in Nordea’s Group Leadership Team

Nordea Bank AbpStock exchange release – Changes board/management/auditors17 October 2024 at 7.00 EET Martin Persson has been appointed Head of Asset & Wealth Management and Petteri Änkilä Head of Large Corporates & Institutions. Snorre Storset will step down as Head of Asset & Wealth Management after nine successful years. These changes will take effect as of 1 January 2025. Martin Persson, current Head of Large Corporates & Institutions, has been appointed Head of Asset & Wealth Management. Martin will continue as a member of the Group Leadership Team and country branch manager

Eisai will request reconsideration of initial decision for lecanemab in Australia

Stockholm, Sweden October 17, 2024 – BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that the Therapeutic Goods Administration (TGA) of Australia issued a public statement about the initial decision not to register the humanized anti-soluble aggregated amyloid-beta (Aβ) monoclonal antibody lecanemab for the treatment of patients with mild cognitive impairment (MCI) due to Alzheimer’s disease (AD) and mild AD dementia.Eisai will request a reconsideration of this initial decision under Section 60 of the Therapeutic Goods Act within 90 days to make lecanemab

Home Security Tips For The Holiday Season

The holiday season is a time for joy and celebration, but it can also be a time for increased crime rates. With homes filled with valuable gifts and families away visiting family, it’s important to take extra precautions to protect your home and belongings.   [A house with snow on the ground Description automatically generated]   Below, home security expert Alison Peckham at MyJobQuote.co.uk  will go over a range of ways in which you can increase the safety and security of your home. Some examples include securing the doors, setting up a security

Lundin Mining Pre-Announces Items Impacting the Third Quarter 2024 Results

VANCOUVER, BC, October 16, 2024 /CNW/ - (TSX: LUN; Nasdaq Stockholm: LUMI) Lundin Mining Corporation (“Lundin Mining” or the “Company”) is pre-announcing certain items impacting the Company’s quarterly earnings, adjusted earnings before interest, taxes, depreciation and amortization (“adjusted EBITDA”)[1], adjusted earnings[1] and adjusted earnings per share[1]. Foreign Exchange and Derivatives Items of significant impact in the third quarter 2024 are expected to include unaudited foreign exchange and trading gains on debt and equity investments supporting the capital funding for the

Catena upgraded to ”BBB” by Fitch

The credit rating agency Fitch Ratings has upgraded its long-term credit rating on Catena to BBB from BBB-. The outlook is stable.16 October 2024, 8.20 p.m. CEST The new rating reflects improvements in Catena's business and financial profile accompanied with an increased trust from the capital market. A growing, modern and energy efficient property portfolio, well positioned geographically has also had an impact on the assessment together with a longer average debt maturity and maintained solid liquidity. “We are proud of the development of Catena and pleased that Fitch has decided to

Inside information: Tietoevry updates its full-year guidance – organic growth around -2% (previous 0-3%) and adj. EBITA 12.3-12.7% (previous 12.0-13.0%) – and provides preliminary key figures for Q3

Tietoevry Corporation               INSIDE INFORMATION             16 October 2024, 8:40 p.m. EEST   Tietoevry has continued to be impacted by the soft IT market, resulting in organic growth of -1% in the third quarter. Market demand weakened compared to the company’s expectations towards the end of the third quarter, and Tietoevry expects soft market conditions to continue for the rest of the year. Weaker demand impacts primarily Tietoevry Create and Tietoevry Tech Services. Certain markets for Tietoevry Care and Tietoevry Industry were also softening in the quarter. Consequently,

There are no items matching the current filter
There are no more items matching the current filter
Back to top